Computer simulation of receptors reveals a new ligand-binding site

July 26, 2018, Ecole Polytechnique Federale de Lausanne

Using a computer simulation of an important receptor, EPFL scientists have discovered a novel binding site for natural ligands and drugs. The new site might be present on other receptors and can be exploited in novel treatments for multiple diseases.

Most biological processes in a cell go through receptors. These are specialized proteins that are activated when a ligand binds to them. Ligands can be all sorts of molecules (e.g. hormones, nucleic acids, neurotransmitters etc), and by binding receptors – and other proteins – they run complex processes such as cell maintenance, immune responses, genetics and others.

These normal cell processes involve complex "dominoes" of biochemical signals that are carried across the cell through protein-ligand interactions. On the other hand, they also lie at the core of a vast number of diseases. An entire branch of research known as "receptor pharmacology" is dedicated to exploiting these interactions with synthetic ligands (drugs), attempting to find ligand-binding sites that can exploited as a drug target.

Now, scientists led by Professor Horst Vogel at EPFL have developed a computer simulation of the widespread muscarinic acetylcholine receptor. Specifically, the scientists examined the M3 and M4 subtypes of the receptor, which are majorly involved in the function of the lungs (M3) and the central nervous system (M3 and M4).

The receptors belong to the large family of so-called "G " (GPCRs), which generally detect signals coming from outside the cells, such as light, hormones, or neurotransmitters. Upon activation, GPCRs change their structure in such a way that they can bind and activate other proteins inside the cell and ultimately turn on the appropriate process.

GPCRs are the target of more than a third of modern therapeutic compounds, meaning that finding new ligand binding sites can help design more efficient GPCR-targeted drugs.

The team used what are known as "molecular dynamics simulations", which is a method for simulating studying the physical movements of atoms and molecules in a computer. The method can reveal details down to the level of individual atoms, thus offering a high-resolution way to look at how various ligands bind on the receptor – and, more importantly, where.

The study revealed a new binding site on the acetylcholine receptors, which can be exploited pharmacologically to understand ligand binding and activation processes. When a ligand binds to the new site, it causes the entire site to expand. The site seems capable of binding small ligands and cause different effects to the receptor than the "main" ligand would.

Looking at more than 200 ligand-bound GPCR structures, the researchers discovered that most ligands bind the traditional ("orthosteric") sites on the receptors. However, one receptor that binds leukotriene (LTB4) and directs immune to sites of infection seemed to bind a "double" , which binds the new site discovered in the two acetylcholine receptors. The new site was detected in many others of the over 200 that the scientists examined.

The study shows that the new binding site might exist in other GPCRs, opening a new opportunity for GPCR drug discovery. "The study shows the power of computational methods to resolve in atomic detail central receptor-mediated signaling reactions," says Horst Vogel. "The challenging next step is to use computational methods to design novel compounds that would fit into the newly found binding sites to activate or deactivate the receptor in a defined mode and thus design novel medicines."

Explore further: Synthetic receptors can rewire cell functions and minimize side-effects

More information: H. C. Stephen Chan et al. Exploring a new ligand binding site of G protein-coupled receptors, Chemical Science (2018). DOI: 10.1039/C8SC01680A

Related Stories

Ties that bind, and can be untied

February 20, 2018

LMU researchers have developed a method that enables cell-surface receptors to be switched on and off at will. The technique promises to provide new insights into receptor functions and their effects on intracellular signaling ...

Tracing water channels in cell surface receptors

September 9, 2014

G protein-coupled receptors (GPCRs) are the largest class of cell surface receptors in our cells, involved in signal transmission across the cell membrane. One of the biggest questions is how a signal recognized at the extracellular ...

CryoEM study captures opioid signaling in the act

June 22, 2018

Opioid drugs like morphine and fentanyl are a mainstay of modern pain medicine. But they also cause constipation, are highly addictive, and can lead to fatal respiratory failure if taken at too high a dose. Scientists have ...

Recommended for you

The friendly extortioner takes it all

February 15, 2019

Cooperating with other people makes many things easier. However, competition is also a characteristic aspect of our society. In their struggle for contracts and positions, people have to be more successful than their competitors ...

A river of stars in the solar neighborhood

February 15, 2019

Astronomy & Astrophysics publishes the work of researchers from the University of Vienna, who have found a river of stars, a stellar stream in astronomical parlance, covering most of the southern sky. The stream is relatively ...

Where is the universe hiding its missing mass?

February 15, 2019

Astronomers have spent decades looking for something that sounds like it would be hard to miss: about a third of the "normal" matter in the Universe. New results from NASA's Chandra X-ray Observatory may have helped them ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.